Covered recipient · General Payments record
BHAGYASHREE SHASTRI
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2022
$749.11
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $198.74 | 10 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $63.50 | 3 |
| ABBVIE INC. | $42.59 | 2 |
| Insmed, Inc. | $35.72 | 2 |
| Corcept Therapeutics | $21.17 | 1 |
| ViiV Healthcare Company | $20.14 | 1 |
| Paratek Pharmaceuticals, Inc. | $15.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.00 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891581493 | CMS |
| ABBVIE INC. | $19.59 | 05/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891581495 | CMS |
| Corcept Therapeutics | $21.17 | 04/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 948794013 | CMS |
| Insmed, Inc. | $15.16 | 05/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 906445921 | CMS |
| Insmed, Inc. | $20.56 | 08/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 906445943 | CMS |
| Novo Nordisk Inc | $17.80 | 02/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899670433 | CMS |
| Novo Nordisk Inc | $22.60 | 06/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898768937 | CMS |
| Novo Nordisk Inc | $23.10 | 07/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899249776 | CMS |
| Paratek Pharmaceuticals, Inc. | $15.62 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 881693541 | CMS |
| ViiV Healthcare Company | $20.14 | 05/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 943985461 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.